Saudi Pharmaceutical Industries & Medical Appliances Corp 2070

Morningstar Rating

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

2070 is trading at a 775% premium.
Price
SAR 34.11
Fair Value
SAR 45.34
Uncertainty
Very High
1-Star Price
SAR 67.17
5-Star Price
SAR 35.76
Economic Moat
Whkd
Capital Allocation

Trading Information

Previous Close Price
Day Range
52-Week Range
Bid/Ask
/
Market Cap
Volume/Avg
/

Key Statistics

Price/Earnings (Normalized)
1,588.22
Price/Sales
2.62
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Total Yield
0.20%

Company Profile

Saudi Pharmaceutical Industries & Medical Appliances Corp is involved in the manufacturing of basic chemical substances and products; medicines for human use, including cosmetics; pharmaceutical production and wholesale and retail of medicines and related products; development and marketing of medicinal and pharmaceutical products; research and development in medical science activities; operating and maintaining the healthcare facilities and any investments in related industries. Its geographical segments are Saudi Arabia, Egypt, the Middle East, Morocco and Algeria.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Growth
Total Number of Employees
309

Comparables

Valuation

Metric
2070
4016
4015
Price/Earnings (Normalized)
1,588.2241.86
Price/Book Value
2.768.359.53
Price/Sales
2.6211.32
Price/Cash Flow
14.4936.36
Price/Earnings
2070
4016
4015

Financial Strength

Metric
2070
4016
4015
Quick Ratio
0.890.003.41
Current Ratio
1.262.744.63
Interest Coverage
1.253,051.60
Quick Ratio
2070
4016
4015

Profitability

Metric
2070
4016
4015
Return on Assets (Normalized)
0.10%20.00%
Return on Equity (Normalized)
0.29%24.16%
Return on Invested Capital (Normalized)
1.76%23.83%
Return on Assets
2070
4016
4015

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
RfvgzmtwdXdtmy$88.3 Bil
Merck KGaA ADR
MKKGY
CdsjjwvzfWcqqv$77.4 Bil
Haleon PLC ADR
HLN
LgbvkhtHcxs$47.3 Bil
Teva Pharmaceutical Industries Ltd ADR
TEVA
QmfjzlqFgzy$19.0 Bil
Viatris Inc
VTRS
ZwxyfsgmGbhj$13.9 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
BchkrfpvwYmwj$13.4 Bil
Catalent Inc
CTLT
PqmfbtdqLpjhjj$10.9 Bil
Prestige Consumer Healthcare Inc
PBH
DvkwprjnyRqkwl$3.5 Bil
Perrigo Co PLC
PRGO
PzpsxqkfRcq$3.5 Bil
Green Thumb Industries Inc
GTBIF
ZppgkvpfrSxyn$2.5 Bil

Sponsor Center